DIAGNOSIS YEAR
Select the diagnosis year first. J’Onco Mentor uses it to establish the standards cycle and to drive year-sensitive routing in this module.
AJCC STAGING SCHEMA / TNM ENTRY
PATHOLOGIC STAGING CRITERIA — HEMATOPOIETIC / LYMPHOMA
Qualifying evidence: Most hematopoietic malignancies do not use conventional AJCC pTNM. Lymphoma staging may use a disease-specific clinical staging system; leukemia and other hematopoietic neoplasms have separate classification frameworks. Do not infer pTNM from biopsy or marrow findings.
pT / pN: Assign only categories supported by the actual pathological evidence and the site-specific AJCC rules. A diagnosis-confirming biopsy does not automatically establish a pathological primary tumor category.
pM: Pathologically proven distant metastasis may support pM1 where the chapter permits; AJCC does not use pM0.
Treatment sequence: Distinguish initial pathological classification (pTNM) from post-neoadjuvant classification (ypTNM). Confirm eligibility, histology, staging chapter and diagnosis-year edition before finalizing.
Source / verification: AJCC · SEER tools and manuals. Educational overview only; verify exact chapter-specific criteria in the licensed AJCC manual.
TNM CAPTURE
| T | — |
|---|---|
| N | — |
| M | — |
—
Use the Hematopoietic Staging Guide for the disease-appropriate staging/classification system.
HEMATOPOIETIC STAGING GUIDE
DIAGNOSIS / HISTOLOGY SEARCH
Search the full C00.0–C80.9 topography list by ICD-O code or site name. Examples: C42.1 or Bone marrow; C77.0 or Lymph nodes of head, face and neck. Choose the exact documented primary site.
LINEAGE:
COMMON / MOST LIKELY PRESENTATION:
REGISTRY PRIMARY SITE:
Do not assign primary site from histology alone. Apply the current Heme DB/Manual primary-site rules to documented disease distribution.
FULL CURRENT SEER HEME DB — 226 NEOPLASMS
The web Heme DB is the authoritative complete catalog and is updated by SEER. Search by morphology code or diagnosis term.
SCHEMA DISCRIMINATOR 1 — AUTO CALCULATOR
—
—
SCHEMA ROUTE: —
PRIMARY SITE GUIDANCE
SEER MULTIPLE PRIMARIES CALCULATOR — HEMATOPOIETIC
Waiting for input
—
—
Enter two morphology codes/diagnoses and diagnosis years.
HEMATOPOIETIC MULTIPLE PRIMARY / TRANSFORMATION REVIEW
COMMON SITES OF INVOLVEMENT — HEMATOPOIETIC / LYMPHOID NEOPLASMS
Hematopoietic and lymphoid neoplasms do not always follow the same “primary solid tumor → metastasis” model. For lymphoma primary-site determination, SEER identifies several sites that are commonly secondary involvement.
Bone
Common secondary/metastatic involvement for lymphoma primary-site determination.
Bone marrow
Common secondary involvement; coded in Mets at Dx—Other when applicable, with important primary-site exceptions.
Distant lymph nodes
Common secondary involvement; treatment of nodal disease depends on the specific lymphoma primary and rules.
Liver
Common secondary involvement.
Lung
Common secondary involvement.
Brain / CNS
Can represent secondary involvement, while true primary CNS lymphomas also exist.